Panic attack nasal spray trial pulled before it began

NCT ID NCT07162649

Terminated Symptom relief Sponsor: Tongji University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to test a nasal spray containing dexmedetomidine for quickly relieving panic attacks in adults. Panic attacks affect about 13% of adults, and current fast-acting treatments can be addictive. The spray was designed to work within minutes. However, the trial was withdrawn before enrolling any participants, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

dexmedetomidine nasal spray

What this could lead to

If it had worked, this could have pointed toward a fast-acting, non-addictive treatment for panic attacks.

What could go wrong

The trial was withdrawn before any participants were enrolled, so no data on safety or effectiveness were collected. It is unknown if the spray would have worked or caused side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEXMEDETOMIDINE